Less Ads, More Data, More Tools Register for FREE

Edison

Edison's team of 50-plus analysts produces award-winning, tier one-standard equity research and investment analysis. In 2023, our international coverage includes daily in-depth scrutiny of over 225 stocks, connecting targeted investor groups across institutions, family offices, wealth managers and retail investors insight into our clients.

Edison specialises in expanding the global capital markets' understanding of our clients' investment cases. We do this through our unique combination of integrated services under the banner Complete IR which enhances our award-winning research with bespoke digital marketing services and investor relations engagement.
Date TIDM Title
25-Sep-24SLPSylvania Platinum - Earnings upside with chrome JV kicker in Q425
25-Sep-240RSLEsker - Proposed bid for the company confirmed
24-Sep-240QNABasilea Pharmaceutica - BARDA backs Basilea’s anti-infectives progr...
24-Sep-24INPPInternational Public Partnerships - Attractive, lower-risk returns
24-Sep-24BOKUBoku - H124 revenue growth supports FY24 outlook
23-Sep-240RDBOryzon Genomics - Final PORTICO data reaffirms potential in BPD
23-Sep-24SUSS&U - Timing is everything
23-Sep-24GROWMolten Ventures - Crystallising portfolio values
23-Sep-24WTANWitan Investment Trust - Merger with Alliance Trust offers many ben...
23-Sep-240QOINewron Pharmaceuticals - Moving full steam towards pivotal studies
19-Sep-24IPOIP Group - Management sees positive portfolio momentum
19-Sep-24CREOCreo Medical - Consumables business divested in strategic move
18-Sep-24UEMUtilico Emerging Markets Trust - Market not reflecting very strong...
18-Sep-24PAAS.USPan American Silver - Strong reserves replacement rates for key assets
18-Sep-24DSCVdiscoverIE Group - Moving into the next growth phase
17-Sep-24SOHOTriple Point Social Housing REIT - Improving rent collection and fu...
17-Sep-24EPWNEpwin Group - Third FY24 EPS uplift this year
16-Sep-24SynBiotic - Platform primed for growth
16-Sep-240KA1Intralot - Improved growth in Q224
16-Sep-24ADSE.USADS-TEC Energy - Progressing to plan
12-Sep-24Attacq - FY24 distributable income outperforms
12-Sep-24CKTCheckit - Contract expansions drive order intake
11-Sep-24OSE.PAOSE Immunotherapeutics - Tedopi registrational study commences
11-Sep-24PEYPartners Group Private Equity - Healthy realisations in H124
11-Sep-24Calgro M3 - Investments support strong revenue pipeline
10-Sep-24AUSTRIACARD - FY24 growth outlook maintained
10-Sep-240K9UHELLENiQ ENERGY - A good quarter, but softer margins expected in Q3
10-Sep-24Verve Group - Driving better media outcomes
09-Sep-240QNABasilea Pharmaceutica - H2 rewards continue: US$25m Cresemba milestone
09-Sep-240RDBOryzon Genomics - First patient dosed in new AML combination study